全文获取类型
收费全文 | 1592篇 |
免费 | 116篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 80篇 |
妇产科学 | 16篇 |
基础医学 | 144篇 |
口腔科学 | 64篇 |
临床医学 | 150篇 |
内科学 | 338篇 |
皮肤病学 | 46篇 |
神经病学 | 78篇 |
特种医学 | 264篇 |
外科学 | 151篇 |
综合类 | 59篇 |
预防医学 | 101篇 |
眼科学 | 29篇 |
药学 | 62篇 |
中国医学 | 9篇 |
肿瘤学 | 114篇 |
出版年
2023年 | 5篇 |
2022年 | 15篇 |
2021年 | 16篇 |
2020年 | 18篇 |
2019年 | 33篇 |
2018年 | 28篇 |
2017年 | 23篇 |
2016年 | 22篇 |
2015年 | 31篇 |
2014年 | 55篇 |
2013年 | 85篇 |
2012年 | 56篇 |
2011年 | 65篇 |
2010年 | 46篇 |
2009年 | 73篇 |
2008年 | 48篇 |
2007年 | 66篇 |
2006年 | 60篇 |
2005年 | 53篇 |
2004年 | 37篇 |
2003年 | 33篇 |
2002年 | 40篇 |
2001年 | 29篇 |
2000年 | 32篇 |
1999年 | 25篇 |
1998年 | 81篇 |
1997年 | 60篇 |
1996年 | 67篇 |
1995年 | 49篇 |
1994年 | 52篇 |
1993年 | 45篇 |
1992年 | 17篇 |
1991年 | 10篇 |
1990年 | 20篇 |
1989年 | 42篇 |
1988年 | 34篇 |
1987年 | 33篇 |
1986年 | 24篇 |
1985年 | 15篇 |
1984年 | 22篇 |
1983年 | 18篇 |
1982年 | 17篇 |
1981年 | 24篇 |
1980年 | 14篇 |
1979年 | 10篇 |
1978年 | 13篇 |
1977年 | 19篇 |
1976年 | 10篇 |
1975年 | 11篇 |
1973年 | 3篇 |
排序方式: 共有1719条查询结果,搜索用时 9 毫秒
31.
Rapid prenatal diagnosis of beta thalassemia using DNA amplification and nonradioactive probes 总被引:3,自引:0,他引:3
We used in vitro DNA amplification by the polymerase chain reaction and nonradioactive probes for prenatal diagnosis of beta thalassemia in Chinese from the Guangdong province. Exact molecular diagnoses were made in all 20 fetuses studied over a 6-month period. We conclude that this method of prenatal diagnosis for beta thalassemia is a viable approach in many parts of the world where this disease is common. 相似文献
32.
Two patients with hairy cell leukemia with massive splenomegaly and severe pancytopenia were treated with recombinant alpha-A interferon (IFN-alpha-2a). There was no significant response to a trial of IFN- alpha-2a (11 and 20 weeks) with respect to blood counts or spleen size. Subsequent treatment with 2'-deoxycoformycin (dCF) for 8 consecutive weeks (4 mg/m2/wk) resulted in normalization of spleen size and a normalization of peripheral blood counts and bone marrow in one patient. The second patient demonstrated a reduction in spleen size and improved blood counts following 9 weeks of dCF therapy but eventually became refractory. This demonstrates that dCF is non-cross-resistant with interferon and confirms the efficacy of dCF in nonsplenectomized patients. 相似文献
33.
34.
35.
36.
A diaper bank and home visiting partnership: Initial exploration of research and policy questions 下载免费PDF全文
37.
38.
39.
Angela Peron Aglaia Vignoli Francesca La Briola Emanuela Morenghi Lucia Tansini Rosa Maria Alfano Gaetano Bulfamante Silvia Terraneo Filippo Ghelma Giuseppe Banderali David H. Viskochil John C. Carey Maria Paola Canevini 《European journal of medical genetics》2018,61(7):403-410
Tuberous Sclerosis Complex (TSC) is a multisystemic condition caused by mutations in TSC1 or TSC2, but a pathogenic variant is not identified in up to 10% of the patients. The aim of this study was to delineate the phenotype of pediatric and adult patients with a definite clinical diagnosis of TSC and no mutation identified in TSC1 or TSC2.We collected molecular and clinical data of 240 patients with TSC, assessing over 50 variables. We compared the phenotype of the homogeneous group of individuals with No Mutation Identified (NMI) with that of TSC patients with a TSC1 and TSC2 pathogenic variant.9.17% of individuals were classified as NMI. They were diagnosed at an older age (p?=?0.001), had more frequent normal cognition (p <?0.001) and less frequent epilepsy (p =?0.010), subependymal nodules (p?=?0.022) and giant cell astrocytomas (p?=?0.008) than patients with TSC2 pathogenic variants. NMI individuals showed more frequent bilateral and larger renal angiomyolipomas (p?=?0.001; p?=?0.003) and pulmonary involvement (trend) than patients with TSC1 pathogenic variants. Only one NMI individual had intellectual disability. None presented with a subependymal giant cell astrocytoma. Other medical problems not typical of TSC were found in 42.86%, without a recurrent pattern of abnormalities. Other TSC-associated neuropsychiatric disorders and drug-resistance in epilepsy were equally frequent in the three groups.This study provides a systematic clinical characterization of patients with TSC and facilitates the delineation of a distinctive phenotype indicative of NMI patients, with important implications for surveillance. 相似文献
40.
CA Tan D. del Gaudio M.A. Dempsey K. Arndt S. Botes A. Reeder S. Das 《Clinical genetics》2014,85(4):353-358
Primary Autosomal Recessive Microcephaly (MCPH) is characterized by congenital microcephaly usually without additional clinical findings. The most common gene implicated in MCPH is ASPM and a large percentage of mutations described have been homozygous and in consanguineous families primarily of East Asian and Middle Eastern origin. ASPM sequencing was performed on 400 patients between the years 2009 and 2012. Seventy of the patient samples were also analyzed for copy number changes in the ASPM gene. Forty protein truncating mutations, including 29 novel mutations, were identified in 39 patients with MCPH. Approximately one third of patients were compound heterozygotes, indicative of non‐consanguinity in these patients. In addition, 46 non‐synonymous variants were identified and interpreted as variants of uncertain significance. No deletion/duplication in ASPM was identified in the patients analyzed. A wide ethnic distribution was observed, including the first reported patients with ASPM‐related MCPH of Hispanic descent. Clinical information was collected for 26 of the ASPM‐positive patients and 41 of the ASPM‐negative patients. As more individuals are identified with MCPH, we anticipate that we will continue to identify ASPM mutation‐positive patients from all ethnic origins supporting the occurrence of this genetic condition beyond that of consanguineous families of certain ethnic populations. 相似文献